These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 2271049)

  • 1. Megakaryocytopoiesis in patients with myelodysplastic syndromes (MDS) with and without del(5q).
    Podolak-Dawidziak M; Geddes D; Bowen D
    Eur J Haematol; 1990 Aug; 45(2):115-6. PubMed ID: 2271049
    [No Abstract]   [Full Text] [Related]  

  • 2. Morphologic analysis in myelodysplastic syndromes with del(5q) treated with lenalidomide. A Japanese multiinstitutional study.
    Matsuda A; Taniwaki M; Jinnai I; Harada H; Watanabe M; Suzuki K; Yanagita S; Suzuki T; Yoshida Y; Kimura A; Tsudo M; Tohyama K; Takatoku M; Ozawa K
    Leuk Res; 2012 May; 36(5):575-80. PubMed ID: 22172461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myelodysplastic syndrome associated with isolated del (5q) chromosome abnormality ("5q- syndrome").
    Maslak P
    Blood; 2007 Dec; 110(12):3825. PubMed ID: 18062093
    [No Abstract]   [Full Text] [Related]  

  • 4. Deletion of 5q31 is observed in megakaryocytic cells in patients with myelodysplastic syndromes and a del(5q), including the 5q- syndrome.
    Godon C; Talmant P; Garand R; Accart F; Bataille R; Avet-Loiseau H
    Genes Chromosomes Cancer; 2000 Dec; 29(4):350-2. PubMed ID: 11066080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone marrow morphology in myelodysplastic syndrome associated with isolated del(5q).
    Naresh KN; Reid A
    Am J Hematol; 2010 Aug; 85(8):609-10. PubMed ID: 20658591
    [No Abstract]   [Full Text] [Related]  

  • 6. Concurrent
    Tremblay-LeMay R; Chang H
    Blood; 2018 Jul; 132(1):112. PubMed ID: 29976782
    [No Abstract]   [Full Text] [Related]  

  • 7. Gaucher disease and myelodysplastic syndrome with isolated del(5q).
    Villarrubia J; Rodríguez-Gambarte JD; Abalo L; Vallés A; Alonso-Domínguez JM; Velasco-Rodríguez D
    Br J Haematol; 2014 Apr; 165(2):164. PubMed ID: 24611589
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical management of myelodysplastic syndromes with interstitial deletion of chromosome 5q.
    Nimer SD
    J Clin Oncol; 2006 Jun; 24(16):2576-82. PubMed ID: 16735711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical, morphological, cytogenetic, and prognostic features of patients with myelodysplastic syndromes and del(5q) including band q31.
    Giagounidis AA; Germing U; Haase S; Hildebrandt B; Schlegelberger B; Schoch C; Wilkens L; Heinsch M; Willems H; Aivado M; Aul C
    Leukemia; 2004 Jan; 18(1):113-9. PubMed ID: 14586479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoplastic myelodysplastic syndrome-a clinical, morphologic, or genetic diagnosis?
    Wong KF; So CC
    Cancer Genet Cytogenet; 2002 Oct; 138(1):85-8. PubMed ID: 12419592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-related inflammatory bone marrow microenvironment induces ineffective erythropoiesis mimicking del(5q) MDS.
    Mei Y; Zhao B; Basiorka AA; Yang J; Cao L; Zhang J; List A; Ji P
    Leukemia; 2018 Apr; 32(4):1023-1033. PubMed ID: 29263441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cryptic deletion of EGR1 in association with a novel balanced t(5;22)(q31;q11.2) in a patient with myelodysplastic syndrome.
    Hoffman MW; Janney S; Batanian JR
    Cancer Genet Cytogenet; 2009 Jun; 191(2):106-8. PubMed ID: 19446747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletion 5q MDS: molecular and therapeutic implications.
    Komrokji RS; Padron E; Ebert BL; List AF
    Best Pract Res Clin Haematol; 2013 Dec; 26(4):365-75. PubMed ID: 24507813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow morphology predicts additional chromosomal abnormalities in patients with myelodysplastic syndrome with del(5q).
    Geyer JT; Verma S; Mathew S; Wang YL; Racchumi J; Espinal-Witter R; Subramaniyam S; Knowles DM; Orazi A
    Hum Pathol; 2013 Mar; 44(3):346-56. PubMed ID: 22995330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myeloid neoplasm with isolated del(5q) and the MPLW515L mutation fulfills the WHO diagnostic criteria for ET.
    Kirito K
    Int J Hematol; 2020 Aug; 112(2):238-242. PubMed ID: 32246278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of myelodysplastic syndrome with isolated del(5q) including bands q31-q33 with a combination of all-trans-retinoic acid and tocopherol-alpha: a phase II study.
    Giagounidis AA; Haase S; Germing U; Schlegelberger B; Wilkens L; Büsche G; Kreipe HH; Wysk J; Grips KH; Grabenhorst U; Rothmann F; Lübbert M; Ganser A; Aivado M; Heinsch M; Aul C
    Ann Hematol; 2005 Jun; 84(6):389-94. PubMed ID: 15785949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specificity of haematological indicators for '5q- syndrome' in patients with myelodysplastic syndromes.
    Teerenhovi L
    Eur J Haematol; 1987 Oct; 39(4):326-30. PubMed ID: 3691757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interphase FISH does not improve the detection of DEL(5q) and DEL(20q) in myelodysplastic syndromes.
    Douet-Guilbert N; Herry A; LE Bris MJ; Guéganic N; Bovo C; Morel F; DE Braekeleer M
    Anticancer Res; 2011 Mar; 31(3):1007-10. PubMed ID: 21498729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multilineage involvement in the 5q- syndrome: a fluorescent in situ hybridization study on bone marrow smears.
    Bigoni R; Cuneo A; Milani R; Cavazzini F; Bardi A; Roberti MG; Agostini P; della Porta M; Specchia G; Rigolin GM; Castoldi G
    Haematologica; 2001 Apr; 86(4):375-81. PubMed ID: 11325642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of myelodysplastic syndrome with abnormal megakaryocytes and ins(8;3)(q24;q21q26).
    Bachy-Delhomme M; Bertheas MF; Jaubert J; Calmard P; Vasselon C; Reynaud J; Brizard CP
    Cancer Genet Cytogenet; 1991 Aug; 55(1):31-4. PubMed ID: 1913604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.